Atlas Trials

Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer

Clinical trial NCT00633204 · UNKNOWN

Trial details

NCT number
NCT00633204
Sponsor
Iwate Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2008-02-01
Primary completion
2011-11-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.